Literature DB >> 26248584

Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia.

Elisabeth Fabian1, Florian Eisner2, Ingrid Pabinger3, Christian Viertler4, Sigrid Regauer4, Andreas Lueger2, Peter Neumeister5, Eva-Christine Weiss6, Wolfgang Schöll6, Uwe Lang6, Florian Prüller7, Guenter J Krejs8.   

Abstract

Entities:  

Keywords:  ADAMTS-13; Complicated pregnancy; HUS (hemolytic uremic syndrome); Plasmapheresis; TMA (thrombotic microangiopathy); TTP (thrombotic thrombocytopenic purpura)

Mesh：

Year:  2015        PMID： 26248584     DOI： 10.1007/s00508-015-0829-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  26 in total

1.  [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

Authors:  C GASSER; E GAUTIER; A STECK; R E SIEBENMANN; R OECHSLIN
Journal:  Schweiz Med Wochenschr       Date:  1955-09-20

2.  Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura.

Authors:  John Chapin; Babette Weksler; Cynthia Magro; Jeffrey Laurence
Journal:  Br J Haematol       Date:  2012-03-13       Impact factor: 6.998

Review 3.  Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.

Authors:  William F Clark
Journal:  Semin Dial       Date:  2012-02-07       Impact factor: 3.455

Review 4.  Methodologies and clinical utility of ADAMTS-13 activity testing.

Authors:  Sarah Just
Journal:  Semin Thromb Hemost       Date:  2010-04-13       Impact factor: 4.180

5.  ADAMTS13 is expressed in hepatic stellate cells.

Authors:  Wenhua Zhou; Mari Inada; Tai-Ping Lee; Daniel Benten; Sergey Lyubsky; Eric E Bouhassira; Sanjeev Gupta; Han-Mou Tsai
Journal:  Lab Invest       Date:  2005-06       Impact factor: 5.662

6.  Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.

Authors:  Fadi Fakhouri; Lubka Roumenina; François Provot; Marion Sallée; Sophie Caillard; Lionel Couzi; Marie Essig; David Ribes; Marie-Agnès Dragon-Durey; Frank Bridoux; Eric Rondeau; Veronique Frémeaux-Bacchi
Journal:  J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 10.121

7.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

8.  Hemolytic-uremic syndrome associated with neuraminidase-producing microorganisms: treatment by exchange transfusion.

Authors:  R Seger; P Joller; K Baerlocher; A Kenny; C Dulake; E Leumann; M Spierig; W H Hitzig
Journal:  Helv Paediatr Acta       Date:  1980-09

Review 9.  STEC-HUS, atypical HUS and TTP are all diseases of complement activation.

Authors:  Marina Noris; Federica Mescia; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

10.  IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  S Ferrari; G C Mudde; M Rieger; A Veyradier; J A Kremer Hovinga; F Scheiflinger
Journal:  J Thromb Haemost       Date:  2009-08-11       Impact factor: 5.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.